Application of exosome derived from human dental pulp stem cells in preparation of medicine
Drug preparation through exosomes derived from human pulp stem cells has been solved, and the problem of major side effects in traditional skin inflammation and psoriasis treatment has been achieved, and safe and effective skin inflammation and psoriasis treatment has been achieved.
Patent Information
- Application Number
- CN202510819637.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-06-19
- Publication Date
- 2025-08-12
AI Technical Summary
Traditional drugs for treating skin inflammation and psoriasis have problems such as major side effects, liver and kidney toxicity and metabolic difficulties, and long-term use has limited its application.
Exosomes derived from human pulp stem cells are used as drug components, and purified exosomes are extracted and purified through specific centrifugation and mixing steps, and are used to prepare drugs for the treatment of skin inflammation and psoriasis, leveraging their powerful immune regulation and tissue penetration capabilities.
Effectively inhibit excessive inflammatory response of the skin, repair skin damage, promote the recovery of the lesion area, provide safe and effective biological intervention measures, and avoid the side effects of traditional drugs.